SCHEMBL7663530

SCHEMBL7663530

CSc1sccc1NS(=O)(=O)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
HPGD P15428 3/20 0.47
GAA P10253 2/20 0.47
KMT2A Q03164 4/20 0.46
TSHR P16473 2/20 0.44
IL1RN P18510 1/20 0.44
KEAP1 Q14145 1/20 0.44
ERAP1 Q9NZ08 1/20 0.44
POLB P06746 1/20 0.44
HTT P42858 1/20 0.44
RECQL P46063 1/20 0.44
AGTR1 P30556 1/20 0.43
GLO1 Q04760 1/20 0.43
PAX8 Q06710 1/20 0.43
SLC40A1 Q9NP59 1/20 0.43
MEN1 O00255 2/20 0.42
PKM P14618 2/20 0.42
KDM4E B2RXH2 2/20 0.42
HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7247948 0.86 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2HPGDGAAKMT2A
SCHEMBL7673427 0.85 CCR2 (0.52) ALDH1A1SMN1; SMN2HPGDKMT2ATSHR
SCHEMBL7248361 0.84 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2HPGDKMT2AHTT
SCHEMBL7664079 0.83 ATM (0.53) ALDH1A1SMN1; SMN2GAAKMT2APOLB
SCHEMBL7248655 0.81 SLC40A1 (0.45) ALDH1A1SLC40A1PKM
SCHEMBL7665091 0.78 ALDH1A1 (0.47) ALDH1A1HPGDKMT2AGLO1KDM4E
SCHEMBL7663217 0.77 HCRTR1 (0.49) TSHRKEAP1RECQLMAPT
SCHEMBL7248579 0.76 ALDH1A1 (0.52) ALDH1A1GAAKMT2AHTTPKM
SCHEMBL13744463 0.73 IL1RN (0.46) ALDH1A1SMN1; SMN2GAAKMT2AIL1RN
SCHEMBL532975 0.73 ACLY (0.69) ALDH1A1HPGDGAAKMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6492403-B1 TREATING SYMPTOMS OF ACUTE OR CHRONIC DISORDER MEDIATED BY CLASSICAL PATHWAY OF COMPLEMENT CASCADE; PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. 2002-12-10 US disclosed